Progress in Research and Application of HIV-1 TAT-Derived Cell-Penetrating Peptide
- PMID: 27933338
- DOI: 10.1007/s00232-016-9940-z
Progress in Research and Application of HIV-1 TAT-Derived Cell-Penetrating Peptide
Abstract
Human immunodeficiency virus type I (HIV-1) transactivator of transcription (TAT) is encoded by HIV-1. It is a peptide rich in basic amino acids and belongs to the protein transduction domain family. It has been found that HIV-1 TAT and its core peptide segment TAT47-57 play an important role in promoting the cellular uptake of coupled bioactive macromolecules, such as peptides, proteins, oligonucleotides, and drug molecules. HIV-1 TAT can also significantly increase the soluble expression of extrinsic proteins. However, the mechanism behind the cellular uptake of HIV-1 TAT-derived cell-penetrating peptide remains unclear. This review focuses on the research into HIV-1 TAT-derived cell-penetrating peptide over the last years. We briefly discuss TAT's structural features, functions and applications, the mechanism of its cellular internalization, current challenges, and their possible solutions. At the end of this review, we provide a summary and predict the future research directions and potential applications of HIV-1 TAT when it is used as a cell-penetrating peptide.
Keywords: Application; Cell-penetrating peptide; Endocytosis; HIV-1 TAT; Internalization; Mechanism.
Similar articles
-
Internalization routes of cell-penetrating melanoma antigen peptides into human dendritic cells.Exp Dermatol. 2014 Jan;23(1):20-6. doi: 10.1111/exd.12285. Exp Dermatol. 2014. PMID: 24372650
-
Cell-Surface Interactions on Arginine-Rich Cell-Penetrating Peptides Allow for Multiplex Modes of Internalization.Acc Chem Res. 2017 Oct 17;50(10):2449-2456. doi: 10.1021/acs.accounts.7b00221. Epub 2017 Sep 14. Acc Chem Res. 2017. PMID: 28910080
-
Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.J Control Release. 2012 Mar 10;158(2):277-85. doi: 10.1016/j.jconrel.2011.11.007. Epub 2011 Nov 12. J Control Release. 2012. PMID: 22100438
-
Therapeutic applications of the cell-penetrating HIV-1 Tat peptide.Drug Discov Today. 2015 Jan;20(1):76-85. doi: 10.1016/j.drudis.2014.09.017. Epub 2014 Sep 30. Drug Discov Today. 2015. PMID: 25277319 Review.
-
Transport molecules using reverse sequence HIV-Tat polypeptides: not just any old Tat? (WO200808225).Expert Opin Ther Pat. 2009 Sep;19(9):1329-33. doi: 10.1517/17530050902824829. Expert Opin Ther Pat. 2009. PMID: 19555160 Review.
Cited by
-
Near-infrared fluorescent nanoprobe enables noninvasive, longitudinal monitoring of graft outcome in RPE transplantation.Front Med (Lausanne). 2025 May 9;12:1583790. doi: 10.3389/fmed.2025.1583790. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40417666 Free PMC article.
-
A Peptide Inhibitor of the Human Cytomegalovirus Core Nuclear Egress Complex.Pharmaceuticals (Basel). 2022 Aug 23;15(9):1040. doi: 10.3390/ph15091040. Pharmaceuticals (Basel). 2022. PMID: 36145260 Free PMC article.
-
The peptide PROTAC modality: a novel strategy for targeted protein ubiquitination.Theranostics. 2020 Aug 8;10(22):10141-10153. doi: 10.7150/thno.46985. eCollection 2020. Theranostics. 2020. PMID: 32929339 Free PMC article. Review.
-
RETRACTED: Optimized Conjugation of Fluvastatin to HIV-1 TAT Displays Enhanced Pro-Apoptotic Activity in HepG2 Cells.Int J Mol Sci. 2020 Jun 10;21(11):4138. doi: 10.3390/ijms21114138. Int J Mol Sci. 2020. Retraction in: Int J Mol Sci. 2024 Nov 08;25(22):12012. doi: 10.3390/ijms252212012. PMID: 32531976 Free PMC article. Retracted.
-
Cell-Penetrating Antimicrobial Peptides with Anti-Infective Activity against Intracellular Pathogens.Antibiotics (Basel). 2022 Dec 8;11(12):1772. doi: 10.3390/antibiotics11121772. Antibiotics (Basel). 2022. PMID: 36551429 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources